CLINICAL_TRIALS
ClinicalTrials.gov record update
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03988842
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:08.910425+00:00
- Published At
- 2021-05-18T00:00:00+00:00
- Record Updated At
- 2021-06-11
- Results Posted At
- 2021-05-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Pulmonary Embolism With Acute Cor Pulmonale", "Pulmonary Embolism", "Pulmonary Embolism With Pulmonary Infarction", "Pulmonary Embolism Subacute Massive", "Right Ventricular Dysfunction", "Right Ventricular Failure"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-06-11"- protocolSection.identificationModule.nctId
"NCT03988842"- protocolSection.identificationModule.officialTitle
"Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-05-18"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.